Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1977 1
1987 2
1988 1
1989 2
1994 2
1995 4
1996 1
1997 2
1998 2
1999 1
2000 4
2001 5
2002 3
2003 4
2004 6
2005 3
2006 9
2007 11
2008 17
2009 10
2010 10
2011 11
2012 9
2013 9
2014 11
2015 5
2016 8
2017 11
2018 10
2019 8
2020 11
2021 17
2022 19
2023 10
2024 10
2025 11
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

245 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
De Corso E, Pasquini E, Trimarchi M, La Mantia I, Pagella F, Ottaviano G, Garzaro M, Pipolo C, Torretta S, Seccia V, Cantone E, Ciofalo A, Lucidi D, Fadda GL, Pafundi PC, Settimi S, Montuori C, Anastasi F, Pagliuca G, Ghidini A, Cavaliere C, Maffei M, Bussu F, Gallo S, Canevari FRM, Paludetti G, Galli J; Dupireal Italian Study Group. De Corso E, et al. Among authors: maffei m. Allergy. 2023 Oct;78(10):2669-2683. doi: 10.1111/all.15772. Epub 2023 May 26. Allergy. 2023. PMID: 37203259 Free article.
Two-Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage.
De Corso E, Montuori C, Pipolo C, La Mantia I, Pasquini E, Ghidini A, Seccia V, Ottaviano G, Cantone E, Dané G, Garzaro M, Fadda GL, Torretta S, Anastasi F, Canevari FRM, Pagella F, Lucidi D, Cavaliere C, Pagliuca G, Maffei M, Bussu F, Corbò M, D Auria LM, De Maio G, Loperfido A, Gallo S, D Agostino G, Giannarelli D, Galli J; DUPIREAL Italian Study Group. De Corso E, et al. Among authors: maffei m. Allergy. 2026 Feb;81(2):388-401. doi: 10.1111/all.70032. Epub 2025 Aug 30. Allergy. 2026. PMID: 40884177
Fine-Tuning Next-Generation Genome Editing Tools.
Kanchiswamy CN, Maffei M, Malnoy M, Velasco R, Kim JS. Kanchiswamy CN, et al. Among authors: maffei m. Trends Biotechnol. 2016 Jul;34(7):562-574. doi: 10.1016/j.tibtech.2016.03.007. Epub 2016 May 8. Trends Biotechnol. 2016. PMID: 27167723 Free article. Review.
Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Paris, France, 20-21 May 2025.
Vatier C, Araújo-Vilar D, Akinci B, Arnould T, Beaupère C, Bismuth E, Brown RJ, Ceccarini G, Collas P, Gambineri A, Gilio D, Halperin S, Janmaat S, Lamothe S, Lattanzi G, Maffei M, MacDougald OA, Mosbah H, Nobecourt E, Oral EA, Rochford J, Santini F, Schirmer EC, von Schnurbein J, Semple R, Tews D, Wabitsch M, Vantyghem MC, Vigouroux C. Vatier C, et al. Among authors: maffei m. Ann Endocrinol (Paris). 2025 Sep;86(5):102432. doi: 10.1016/j.ando.2025.102432. Epub 2025 Jul 30. Ann Endocrinol (Paris). 2025. PMID: 40749787
Chromosomal Deletion Involving ANKRD26 Leads to Expression of a Fusion Protein Responsible for ANKRD26-Related Thrombocytopenia.
Dell'Orso G, Passarella T, Cappato S, Cappelli E, Regis S, Maffei M, Balbi M, Ravera S, Di Martino D, Viaggi S, Davì S, Corsolini F, Giarratana MC, Arcuri L, Mariani E, Morini R, Massaccesi E, Guardo D, Calvillo M, Palmisani E, Coviello D, Fioredda F, Dufour C, Bocciardi R, Miano M. Dell'Orso G, et al. Among authors: maffei m. Int J Mol Sci. 2025 Jul 29;26(15):7330. doi: 10.3390/ijms26157330. Int J Mol Sci. 2025. PMID: 40806462 Free PMC article.
245 results